Ibandronate Sodium Tablets

Award Notice Posted

Solicitation number
SPE2D2-26-D-0015
Agency
Awarded
to Golden State Medical Supply, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-26-D-0015 Federal IDV award
Place of performance
Etobicoke Ontario Canada

Notice details come from SAM.gov. Updated .

About this opportunity

Defense Logistics Agency Troop Support Medical awarded contract SPE2D2-26-D-0015 to Golden State Medical Supply, Inc. for $2,364,029.99 on May 7, 2026, for supply of Ibandronate Sodium Tablet 150MG in 3-count packs.

The contract term is five years. Base year quantity is 27,881 packs at $16.94 per unit ($472,304.14), with four option years at $16.97 per unit ($473,140.57 each). The product is manufactured by Apotex Corporation at its facility in Etobicoke, Ontario, Canada. Intermediate packaging and labeling occur at the same Apotex location; final packing and shipment preparation occur at Golden State Medical Supply in Camarillo, California. The award was made under unrestricted competition with no set-aside applied. DLA Pharmaceutical Prime Vendors (AmerisourceBergen Drug Corporation, Cardinal Health Inc., DMS Pharmaceutical Group, Inc., and McKesson Corp.) are identified as the distribution channel; invoices are submitted through the prime vendor network. The contract incorporates FAR 52.212-4 and 52.212-5 with deviations 2025-O0003 and 2025-O0004.

Notice text

SPE2D2-26-D-0015 Ibandronate Sodium Award

Awarded contract SPE2D2-26-D-0015 to GOLDEN STATE MEDICAL SUPPLY, INC. for 2364029.99 on 2026-05-07.

Files

Notice history

Notice Type Posted
This notice Award Award Notice
Ibandronate Sodium Tablets Latest solicitation Solicitation
Ibandronate Sodium Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity